BioWorld

Jan. 31, 2006

View Archived Issues

CV Therapeutics Gets FDA OK To Sell Ranexa In Angina

At last, the FDA cleared Ranexa (ranolazine extended-release tablets), the first new angina drug approved in the U.S. in more than 20 years. (BioWorld Today) Read More

CombinatoRx's Osteo Drug Proves Beneficial In Phase II

Read More

Starting From No Activity Yields New Anti-Alzheimer's Chemical

Read More

CytRx Forming Subsidiary To Accelerate RNAi Work

Read More

Other News To Note

Read More